Clinical significance of the loss of CD20 antigen on tumor cells in patients with relapsed or refractory follicular lymphoma
Research advances and new challenges in overcoming triple-negative breast cancer
Emerging RAS-directed therapies for cancer
The implication of liquid biopsies to predict chemoresistance in pancreatic cancer
Targeting the PI3K/AKT/mTOR pathway in epithelial ovarian cancer, therapeutic treatment options for platinum-resistant ovarian cancer
Cost-effectiveness of Osimertinib in activating epidermal growth factor receptor gene (<i>EGFR</i>)-mutations in first-line for advanced non-small cell lung cancer
Targeting mTOR and eIF4E: a feasible scenario in ovarian cancer therapy
Protective autophagy by thymidine causes resistance to rapamycin in colorectal cancer cells <i>in vitro</i>
Favorable clinical outcomes of checkpoint inhibitor-based combinations after progression with immunotherapy in advanced non-small cell lung cancer
Mechanisms of resistance to FGFR1 inhibitors in FGFR1-driven leukemias and lymphomas: implications for optimized treatment
ATP-binding cassette transporters at the zebrafish blood-brain barrier and the potential utility of the zebrafish as an <i>in vivo </i>model
Proteasomal adaptations to FDA-approved proteasome inhibitors: a potential mechanism for drug resistance?